Managed care branded OTC reimbursement strategy ill-advised, consultant tells AAPS.
This article was originally published in The Tan Sheet
Executive Summary
BRANDED OTC MANAGED CARE REIMBURSEMENT STRATEGY "SUICIDAL," in the opinion of industry consultant William Howard, PhD. Speaking at the American Association of Pharmaceutical Scientists annual meeting in Boston Nov. 2-6, the founder of the Morris Plains, N.J.-based pharmaceutical software/management firm SDM acknowledged that OTC drugs' potential role in managed care remains a "hot topic" among many in the OTC industry but warned against the pursuit of OTC reimbursement, reasoning that such a scenario often is financially detrimental to both the manufacturer and the managed care organization.